HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kit S Lam Selected Research

Ligands

1/2020Rapid endothelialization of small diameter vascular grafts by a bioactive integrin-binding ligand specifically targeting endothelial progenitor cells and endothelial cells.
10/2019High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
9/2019One-bead one-compound combinatorial library derived targeting ligands for detection and treatment of oral squamous cancer.
7/2019Correction to: High-affinity peptide ligand LXY30 for targeting α3β1 integrin in non-small cell lung cancer.
7/2018Identification of integrin drug targets for 17 solid tumor types.
1/2017Tumor-targeting peptides from combinatorial libraries.
12/2016Discovery and characterization of a high-affinity and high-specificity peptide ligand LXY30 for in vivo targeting of α3 integrin-expressing human tumors.
10/2016Novel theranostic nanoporphyrins for photodynamic diagnosis and trimodal therapy for bladder cancer.
1/2015Design, synthesis, and application of OB2C combinatorial peptide and peptidomimetic libraries.
10/2013Telodendrimer-based nanocarriers for the treatment of ovarian cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kit S Lam Research Topics

Disease

92Neoplasms (Cancer)
01/2022 - 01/2002
21Breast Neoplasms (Breast Cancer)
01/2021 - 09/2003
14Lymphoma (Lymphomas)
01/2015 - 09/2003
13Ovarian Neoplasms (Ovarian Cancer)
10/2017 - 05/2005
11Neoplasm Metastasis (Metastasis)
11/2019 - 11/2006
9Prostatic Neoplasms (Prostate Cancer)
01/2018 - 11/2006
8Glioblastoma (Glioblastoma Multiforme)
01/2022 - 05/2005
8B-Cell Lymphoma (Lymphoma, B Cell)
05/2018 - 09/2007
7Inflammation (Inflammations)
01/2022 - 01/2006
7Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
09/2013 - 05/2003
6Leukemia
01/2019 - 01/2006
6Urinary Bladder Neoplasms (Bladder Cancer)
01/2018 - 01/2012
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2021 - 08/2015
4Lung Neoplasms (Lung Cancer)
11/2018 - 09/2007
4Alzheimer Disease (Alzheimer's Disease)
02/2011 - 01/2007
3Carcinoma (Carcinomatosis)
01/2021 - 01/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2019 - 10/2012
3Cardiotoxicity
05/2018 - 10/2011
3Autoimmune Diseases (Autoimmune Disease)
02/2008 - 01/2006
2Triple Negative Breast Neoplasms
01/2021 - 10/2019
2Brain Neoplasms (Brain Tumor)
04/2020 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2019 - 12/2012
2Mouth Neoplasms (Oral Cancer)
09/2019 - 11/2018
2Carcinogenesis
12/2012 - 11/2012
2Melanoma (Melanoma, Malignant)
09/2011 - 10/2010

Drug/Important Bio-Agent (IBA)

36Pharmaceutical PreparationsIBA
10/2021 - 01/2002
35Peptides (Polypeptides)IBA
01/2022 - 01/2002
28LigandsIBA
01/2020 - 09/2003
19IntegrinsIBA
01/2021 - 05/2005
19MicellesIBA
01/2021 - 06/2010
11Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 10/2009
9Proteins (Proteins, Gene)FDA Link
01/2019 - 01/2007
8Cyclic PeptidesIBA
10/2019 - 10/2005
8PeptidomimeticsIBA
01/2015 - 01/2006
7Cell Surface ReceptorsIBA
01/2021 - 01/2002
7DisulfidesIBA
01/2019 - 09/2011
6AcidsIBA
04/2020 - 09/2003
6Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019 - 10/2011
6Integrin alpha4beta1 (VLA-4)IBA
05/2012 - 07/2006
5Biomarkers (Surrogate Marker)IBA
09/2019 - 07/2006
5Peptide LibraryIBA
09/2019 - 09/2007
5Polysaccharides (Glycans)IBA
02/2014 - 07/2006
5Integrin alpha3IBA
11/2009 - 05/2005
5AntibodiesIBA
01/2009 - 01/2002
5Monoclonal AntibodiesIBA
06/2008 - 01/2002
4Amyloid beta-PeptidesIBA
10/2021 - 01/2007
4CY5.5 cyanine dyeIBA
10/2019 - 10/2005
4EnzymesIBA
10/2011 - 01/2007
3StreptavidinIBA
10/2019 - 10/2005
3DNA (Deoxyribonucleic Acid)IBA
10/2019 - 12/2008
3Daunorubicin (Cerubidine)FDA LinkGeneric
01/2019 - 10/2012
3Conditioned Culture MediaIBA
01/2019 - 07/2006
3Acetylcysteine (Siran)FDA LinkGeneric
05/2018 - 09/2011
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2018 - 01/2016
3Amino AcidsFDA Link
03/2017 - 11/2006
3Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
10/2016 - 04/2009
3Immunoconjugates (Immunoconjugate)IBA
01/2016 - 01/2007
3AutoantibodiesIBA
09/2013 - 08/2007
3TenecteplaseFDA Link
01/2009 - 01/2007
3Glycoproteins (Glycoprotein)IBA
09/2008 - 07/2006
3Radioisotopes (Radionuclides)IBA
09/2008 - 09/2007
3XenobioticsIBA
08/2007 - 05/2004
3AutoantigensIBA
05/2005 - 05/2003
2Extracellular Matrix ProteinsIBA
04/2020 - 11/2006
2HydrogelsIBA
01/2020 - 01/2020
2PolymersIBA
01/2020 - 09/2003
2Biological ProductsIBA
01/2020 - 01/2012
2Galectin 1 (LGALS1)IBA
11/2019 - 01/2018
2RNA (Ribonucleic Acid)IBA
11/2019 - 05/2017
21-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
11/2019 - 01/2018
2Biotin (Vitamin H)FDA Link
10/2019 - 10/2005
2Cholic AcidIBA
01/2019 - 10/2016
2Drug CombinationsIBA
12/2018 - 05/2017
2osimertinibIBA
11/2018 - 01/2018
2AndrogensIBA
01/2018 - 01/2010
2Docetaxel (Taxotere)FDA Link
01/2018 - 06/2017
2Coloring Agents (Dyes)IBA
10/2017 - 06/2012
2SolutionsIBA
05/2017 - 10/2016
2MicroRNAs (MicroRNA)IBA
05/2017 - 11/2012
2Androgen Receptors (Androgen Receptor)IBA
01/2016 - 01/2016
2Transcription Factors (Transcription Factor)IBA
04/2015 - 09/2011
2Secretory Phospholipases A2IBA
01/2015 - 01/2013
2Caspase 3 (Caspase-3)IBA
01/2015 - 01/2014
2Alanine (L-Alanine)FDA Link
09/2013 - 11/2006
2matrigelIBA
12/2012 - 09/2010
2Fluorescent Dyes (Fluorescent Probes)IBA
09/2012 - 07/2006
2Reducing AgentsIBA
06/2012 - 09/2011
2cremophor ELIBA
01/2012 - 06/2010

Therapy/Procedure

39Therapeutics
10/2021 - 09/2004
12Drug Therapy (Chemotherapy)
01/2021 - 12/2008
6Precision Medicine
01/2020 - 01/2012
4Radioimmunotherapy
01/2022 - 01/2007
4Lasers (Laser)
01/2021 - 01/2015
3Radiotherapy
01/2022 - 01/2019
3Intravenous Injections
01/2021 - 10/2005
3Immunotherapy
01/2020 - 09/2007
3Photochemotherapy (Photodynamic Therapy)
01/2018 - 01/2016
3Castration
01/2018 - 01/2016
2Phototherapy (Light Therapy)
01/2020 - 01/2016
2Microbubbles
01/2018 - 07/2012